NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT00323063 2023-03-29Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast CancerRutgers, The State University of New JerseyPhase 2 Terminated49 enrolled 11 charts
NCT00080665 2018-04-24Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast CancerSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1 Completed12 enrolled
NCT00087152 2014-06-09S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast CancerNational Cancer Institute (NCI)Phase 2 Completed27 enrolled 9 charts
NCT00045188 2013-01-23Imatinib Mesylate in Treating Patients With Metastatic Breast CancerNational Cancer Institute (NCI)Phase 2 Completed35 enrolled